🇺🇸 Combination of low ICS and montelukast in United States

Combination of low ICS and montelukast (Combination of low ICS and montelukast) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Combination of low ICS and montelukast in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Combination of low ICS and montelukast approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Combination of low ICS and montelukast in United States?

Ajou University School of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.